Pharmaceutical Industry of the United States is prepared to spend 80 billion dollars over 10 years for the reform of American health care, which is being developed by the administration of U.S. President Barack Obama.
Democrat Senator Max Bokus has managed to negotiate with pharmaceutical associations on the bill on the reform to transfer part of program costs on the shoulders of businesses, passes Associated Press.
The agreement between the White House, lawmakers and the pharmaceutical industry should facilitate access to prescription drugs for millions of older Americans and reduce costs of the federal government.
B. Obama welcomed the agreement that was reached by the senator and pharmaceutical companies, describing it as a “turning point” in improving the national health system.
The current U.S. public health system, by the general view of American politicians, is imperfect and is in need of immediate reform. Approximately 46 million people in the country are not covered by a health insurance program, the budgetary costs of Medicaid and Medicare programs are growing at a daunting pace and the budget already has a huge deficit.
Congressmen, working on the reform bill, hope that the cost of the plan will not exceed 1 trillion U.S.